Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tenaya Therapeutics Inc (TNYA)

Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tenaya Therapeutics Inc 171 OYSTER POINT BOULEVARD SUITE 500 SOUTH SAN FRANCISCO CA 94080 USA

www.tenayatherapeutics.com P: 650-825-6990

Description:

Tenaya Therapeutics Inc. is a biotechnology company. It discovers, develop and deliver curative therapies which address the underlying causes of heart disease. The company's product platform consist Gene Therapy, Cellular Regeneration and Precision Medicine. Tenaya Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 367,464
Enterprise Value, $K 321,784
Shares Outstanding, K 78,518
Annual Sales, $ 0 K
Annual Net Income, $ -124,080 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -29,940 K
EBIT, $ -131,190 K
EBITDA, $ -122,190 K
60-Month Beta 2.61
% of Insider Shareholders 33.83%
% of Institutional Shareholders 90.54%
Float, K 51,955
% Float 66.17%
Short Volume Ratio 0.55

Growth:

1-Year Return -20.81%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.40 on 03/18/24
Latest Earnings Date 05/08/24 [--]
Earnings Per Share ttm -1.67
EPS Growth vs. Prev Qtr -2.56%
EPS Growth vs. Prev Year 34.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TNYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.94%
Return-on-Assets % -59.80%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.26
Book Value/Share 2.05
Interest Coverage -2.74
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar